SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Vivos Therapeutics Q3 net loss narrows 64% year over year to $1.97 million

Vivos Therapeutics Q3 net loss narrows 64% year over year to $1.97 million Vivos Therapeutics' t

VVOS

Related stories